Cameron C Grant1, Mei-Hua Chen2, Dinusha K Bandara2, Emma J Marks3, Catherine A Gilchrist4, Sonia Lewycka5, Polly E Atatoa Carr6, Elizabeth M Robinson7, Jan E Pryor8, Carlos A Camargo9, Susan M B Morton10. 1. Centre for Longitudinal Research - He Ara ki Mua, The University of Auckland, Auckland, New Zealand; Starship Children's Hospital, Auckland District Health Board, Auckland, New Zealand. Electronic address: cc.grant@auckland.ac.nz. 2. Growing Up in New Zealand, The University of Auckland, Auckland, New Zealand. 3. Growing Up in New Zealand, The University of Auckland, Auckland, New Zealand; Bioinformatics Institute, The University of Auckland, Auckland, New Zealand. 4. Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand. 5. Centre for Longitudinal Research - He Ara ki Mua, The University of Auckland, Auckland, New Zealand. 6. Centre for Longitudinal Research - He Ara ki Mua, The University of Auckland, Auckland, New Zealand; Growing Up in New Zealand, The University of Auckland, Auckland, New Zealand; Waikato Clinical School, The University of Auckland, Hamilton, New Zealand. 7. Growing Up in New Zealand, The University of Auckland, Auckland, New Zealand; Department of Epidemiology and Biostatistics, School of Population Health, The University of Auckland, Auckland, New Zealand. 8. Growing Up in New Zealand, The University of Auckland, Auckland, New Zealand; Roy McKenzie Centre for the Study of Families, Victoria University, New Zealand. 9. Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, USA. 10. Centre for Longitudinal Research - He Ara ki Mua, The University of Auckland, Auckland, New Zealand; Growing Up in New Zealand, The University of Auckland, Auckland, New Zealand.
Abstract
BACKGROUND: Most women decide about infant immunisation during pregnancy. However, we have limited knowledge of the immunisation intentions of their partners. We aimed to describe what pregnant women and their partners intended for their future child's immunisations, and to identify associations between parental intentions and the subsequent timeliness of infant immunisation. METHODS: We recruited a cohort of pregnant New Zealand (NZ) women expecting to deliver between April 2009 and March 2010. The cohort included 11% of births in NZ during the recruitment period and was generalisable to the national birth cohort. We completed antenatal interviews independently with mothers and partners. We determined immunisation receipt from the National Immunisation Register and defined timely immunisation as receiving all vaccines (scheduled at 6-weeks, 3- and 5-months) within 30 days of their due date. We described independent associations of immunisation intentions with timeliness using adjusted odds ratios (OR) and 95% confidence intervals (CI). RESULTS: Of 6172 women, 5014 (81%) intended full immunisation, 245 (4%) partial immunisation, 140 (2%) no immunisation and 773 (13%) were undecided. Of 4152 partners, 2942 (71%) intended full immunisation, 208 (5%) partial immunisation, 83 (2%) no immunisation and 921 (22%) were undecided. Agreement between mothers and partners was moderate (Kappa=0.42). Timely immunisation occurred in 70% of infants. Independent of their partner's intentions, infants of pregnant women who decided upon full immunisation were more likely to be immunised on time (OR=7.65, 95% CI: 4.87-12.18). Independent of the future mother's intentions, infants of partners who had decided upon full immunisations were more likely to be immunised on time (OR=3.33, 95% CI: 2.29-4.84). CONCLUSIONS: During pregnancy, most future parents intend to fully immunise their child; however, more partners than mothers remain undecided about immunisation. Both future mothers' and future fathers' intentions are independently associated with the timeliness of their infant's immunisations.
BACKGROUND: Most women decide about infant immunisation during pregnancy. However, we have limited knowledge of the immunisation intentions of their partners. We aimed to describe what pregnant women and their partners intended for their future child's immunisations, and to identify associations between parental intentions and the subsequent timeliness of infant immunisation. METHODS: We recruited a cohort of pregnant New Zealand (NZ) women expecting to deliver between April 2009 and March 2010. The cohort included 11% of births in NZ during the recruitment period and was generalisable to the national birth cohort. We completed antenatal interviews independently with mothers and partners. We determined immunisation receipt from the National Immunisation Register and defined timely immunisation as receiving all vaccines (scheduled at 6-weeks, 3- and 5-months) within 30 days of their due date. We described independent associations of immunisation intentions with timeliness using adjusted odds ratios (OR) and 95% confidence intervals (CI). RESULTS: Of 6172 women, 5014 (81%) intended full immunisation, 245 (4%) partial immunisation, 140 (2%) no immunisation and 773 (13%) were undecided. Of 4152 partners, 2942 (71%) intended full immunisation, 208 (5%) partial immunisation, 83 (2%) no immunisation and 921 (22%) were undecided. Agreement between mothers and partners was moderate (Kappa=0.42). Timely immunisation occurred in 70% of infants. Independent of their partner's intentions, infants of pregnant women who decided upon full immunisation were more likely to be immunised on time (OR=7.65, 95% CI: 4.87-12.18). Independent of the future mother's intentions, infants of partners who had decided upon full immunisations were more likely to be immunised on time (OR=3.33, 95% CI: 2.29-4.84). CONCLUSIONS: During pregnancy, most future parents intend to fully immunise their child; however, more partners than mothers remain undecided about immunisation. Both future mothers' and future fathers' intentions are independently associated with the timeliness of their infant's immunisations.
Authors: Catherine A Gilchrist; Carol Chelimo; Ryan Tatnell; Polly Atatoa Carr; Carlos A Camargo; Susan Morton; Cameron C Grant Journal: Hum Vaccin Immunother Date: 2021-11-19 Impact factor: 3.452